Preventing DILE involves careful selection and monitoring of medications, especially in individuals with known risk factors. Clinicians should consider alternative medications with a lower risk of inducing lupus in susceptible patients. Regular follow-up and awareness of the early signs and symptoms of DILE can facilitate prompt intervention, minimizing the impact of this condition.
